Gene therapy for sickle cell disease passes key preclinical test
4.8 (169) · $ 17.99 · In stock
A precision-engineered gene therapy virus, inserted into blood stem cells that are then transplanted, markedly reduced sickle-induced red-cell damage in mice with sickle cell disease, researchers from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center reported in the Journal of Clinical Investigation.
Денис Савин (@withoutpassions) / X
Dr.mrs jugesh saluja (@jugeshsaluja) / X
Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette
The daily dilemmas of a student with sickle cell anaemia, Students
Archives — Page 198 of 873 — Harvard Gazette
Archives — Page 250 of 998 — Harvard Gazette
Archives — Page 198 of 873 — Harvard Gazette
Archives — Page 198 of 873 — Harvard Gazette
News & Events - latest news and happenings in the SCD community
Rectal Bleeding (Blood in Stool): Causes, Colors & Treatments
